Gilead Sciences, Inc. Financial Ratios — GILD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	189.3	94.53	62.66	128.45	117.83	74.68	24.9	28.68	28.04	0.73	40.54	28.69	35.41	3.45	67.46
Return on Assets (%)	19.41	13.45	14.04	42.28	41.93	24.84	7.27	8.14	8.6	0.19	9.13	7	9.04	0.79	14.42
Return on Capital (%)	41.2	26.44	26.22	64.57	56.48	33.35	10.24	12.52	- -	0.47	15.76	12.76	15.81	2.92	24.51
Return on Invested Capital (%)	24.36	17.96	18.43	53.74	54.43	32.6	9.75	12.67	- -	1.1	16.76	18.29	15.25	15.52	21.77
Gross Margin (%)	74.67	74.53	74.48	84.78	87.73	85.98	83.26	78.07	79.18	81.48	75.82	79.26	76.04	78.26	78.83
EBITDA Margin (%)	48.8	44.2	43.47	65.55	71.36	61.83	59.03	48.48	47.85	46.2	47.27	47.93	42.52	46.47	49.12
Operating Margin (%)	45.2	41.33	40.39	61.33	68	58.02	54.1	42.02	41.6	40.21	39.76	40.23	32.59	36.85	39.74
Incremental Operating Margin (%)	-39.54	16.72	34.27	78.47	89.41	202.76	81.93	121.26	12.42	26.29	35.55	-487.5	1,294.55	107.33	160.61
Pretax Margin (%)	43.54	37.23	37.56	59.69	66.36	56.26	51.82	35.25	22.99	6.76	30.32	21.31	25.3	2.4	33.27
Profit Margin (%)	33.43	26.72	27.45	48.62	55.48	44.43	17.73	24.65	23.99	0.5	22.8	16.83	20.89	1.67	28.9
Net Income to Common Margin (%)	33.43	26.72	27.45	48.62	55.48	44.43	17.73	24.65	23.99	0.5	22.8	16.83	20.89	1.67	28.9
Effective Tax Rate (%)	23.61	28.74	27.35	18.83	16.4	21.11	65.67	29.99	- -	94.67	25.09	21.47	18.18	30.58	13.13
Dvd Payout Ratio (%)	- -	- -	- -	- -	10.35	18.22	58.61	54.36	60.31	6,270.91	58.36	81.7	68.51	817.95	47.04
Sustainable Growth Rate (%)	189.3	94.53	62.66	128.45	105.63	61.07	10.31	13.09	11.13	-44.95	16.88	5.25	11.15	-24.79	35.73

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	7,607	8,224	6,636	12,404	22,055	26,346	33,542	27,322	24,593	31,402	26,695	25,230	24,987	26,711	24,936
ST Debt	2	1,169	2,697	483	982	- -	2,747	2,748	2,499	2,757	1,516	2,273	1,798	1,815	2,807
LT Debt	7,606	7,055	3,939	11,921	21,073	26,346	30,795	24,574	22,094	28,645	25,179	22,957	23,189	24,896	22,129
Total Debt/EBITDA	1.86	1.92	1.36	0.76	0.95	1.4	2.18	2.55	2.29	2.75	2.07	1.93	2.17	2	1.72
Net Debt/EBITDA	-0.56	1.5	0.93	0.15	0.4	0.96	1.68	0.87	1.21	2.23	1.65	1.52	1.64	1.25	1.2
Total Debt/EBIT	2.01	2.05	1.47	0.81	0.99	1.49	2.37	2.94	2.63	3.16	2.46	2.3	2.83	2.52	2.13
Net Debt/EBIT	-0.6	1.6	1	0.16	0.41	1.03	1.84	1.01	1.39	2.56	1.97	1.81	2.14	1.58	1.48
EBITDA to Interest Expense	19.92	11.88	15.86	39.6	33.85	19.49	13.78	9.96	10.8	11.59	12.89	13.99	12.22	13.68	14.12
EBITDA-CapEx/Interest Expense	19.92	11.88	15.86	39.6	33.85	19.49	13.78	9.96	10.8	11.59	12.89	13.99	11.6	13.14	13.57
EBIT to Interest Expense	18.45	11.11	14.74	37.05	32.26	18.29	12.63	8.63	9.38	10.09	10.85	11.74	9.36	10.85	11.43
Interest Expense	205	361	307	412	688	964	1,118	1,077	995	984	1,001	935	944	977	1,024
Common Equity/Total Assets	10.27	17.45	27.05	36.74	34.81	31.86	27.05	29.88	31.46	21.02	24.02	24.83	26.25	19.49	23.26
Long-Term Debt/Equity (%)	110.75	73.92	33.54	75.36	110.25	136.06	150.21	114.12	97.55	157.21	119.54	108.24	101.93	129.36	97.84
Long-Term Debt/Capital (%)	79.95	57.96	30.03	46.69	51.86	58.58	58.53	52.85	50.09	62.54	58.54	56.15	56.27	65.3	57.35
Long-Term Debt/Total Assets (%)	43.96	33.21	17.45	34.39	40.75	46.24	43.82	38.59	35.85	41.87	37.05	36.34	37.33	42.2	37.49
Total Debt/Equity (%)	110.78	86.17	56.5	78.41	115.39	136.06	163.61	126.88	108.58	172.34	126.73	118.96	109.84	138.79	110.25
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt/Total Assets (%)	43.96	38.72	29.39	35.78	42.65	46.24	47.72	42.91	39.91	45.9	39.29	39.94	40.22	45.28	42.25
Net Debt to Equity	-33.15	67.27	38.51	15.03	48.16	93.57	126.6	43.57	57.23	139.43	101.39	93.44	83.09	86.88	76.81
Net Debt/Capital (%)	614.49	61.93	41.1	15.33	33.13	49.3	57.64	32.86	39.91	63.82	56.68	55.86	53.82	59.43	56
EBITDA	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	11,531	13,363	14,461
EBITDA-CapEx	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	10,946	12,840	13,898
Operating Income (Loss)	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,838	10,596	11,701

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	3.94	0.44	0.33	1.76	1.48	1.29	2.19	2.84	2.5	0.65	0.56	0.57	0.64	0.96	0.81
Current Ratio	5.53	1.45	1.09	3.07	2.5	2.12	2.74	3.38	3.1	1.4	1.27	1.29	1.43	1.6	1.55
Quick Ratio	4.71	0.85	0.67	2.56	2.07	1.78	2.52	3.15	2.86	1.08	0.95	0.99	1.06	1.33	1.23
CFO/Avg Current Liab	1.46	0.95	0.58	2.11	2.72	1.78	1.14	0.76	0.9	0.77	0.99	0.79	0.71	0.93	0.84
Common Equity/Total Assets	10.27	17.45	27.05	36.74	34.81	31.86	27.05	29.88	31.46	21.02	24.02	24.83	26.25	19.49	23.26
Long-Term Debt/Equity (%)	110.75	73.92	33.54	75.36	110.25	136.06	150.21	114.12	97.55	157.21	119.54	108.24	101.93	129.36	97.84
Long-Term Debt/Capital (%)	79.95	57.96	30.03	46.69	51.86	58.58	58.53	52.85	50.09	62.54	58.54	56.15	56.27	65.3	57.35
Long-Term Debt/Total Assets (%)	43.96	33.21	17.45	34.39	40.75	46.24	43.82	38.59	35.85	41.87	37.05	36.34	37.33	42.2	37.49
Total Debt/Equity (%)	110.78	86.17	56.5	78.41	115.39	136.06	163.61	126.88	108.58	172.34	126.73	118.96	109.84	138.79	110.25
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt/Total Assets (%)	43.96	38.72	29.39	35.78	42.65	46.24	47.72	42.91	39.91	45.9	39.29	39.94	40.22	45.28	42.25
CFO/Total Liabilities	34.87	27.32	28.66	68.02	65.18	45.32	23.9	19.93	23.46	16.28	24.28	21.62	20.33	27.24	27.52
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.69	20.7	17.8
Altman's Z-Score	4.26	6.46	10.08	9.36	6.42	4.23	3.65	3.66	3.67	3.93	4.6	4.98	4.64	4.62	5.34

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	4.69	5.24	5.7	7.3	6.22	5.86	6.24	6.17	6.5	5.83	5.82	5.89	5.75	6.33	6.31
Days Sales Outstanding	77.77	69.65	64.08	49.98	58.65	62.26	58.48	59.2	56.17	62.64	62.73	62.01	63.51	57.63	57.85
Inventory Turnover	1.64	1.58	1.66	2.46	2.4	2.41	3.66	6.01	5.39	3.51	4	3.62	3.95	3.58	3.58
Days Inventory Outstanding	222.82	231.54	219.71	148.53	152.2	151.7	99.7	60.73	67.77	103.98	91.26	100.82	92.51	102.1	101.99
Accounts Payable Turnover	2.3	2.23	2.18	3.15	4.29	3.27	3.55	6.07	6.36	6.85	8.44	6.89	9.32	8.93	8.14
Accounts Payable Turnover Days	158.69	163.6	167.72	116.05	85.09	111.76	102.83	60.16	57.35	53.28	43.25	52.98	39.18	40.88	44.86
Cash Conversion Cycle	141.9	137.58	116.08	82.47	125.77	102.21	55.35	59.78	66.59	113.34	110.74	109.85	116.85	118.85	114.99
Inventory to Cash Days	-145.06	-161.89	-155.63	-98.55	-93.56	-89.44	-41.23	-1.53	-11.6	-41.34	-28.54	-38.8	-29	-44.47	-44.14
Inventories	1,390	1,745	1,697	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787	1,710	1,774
Raw Materials	698	827	1,049	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	466	359	413	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	226	560	593	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	-359	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787	1,710	1,774

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	31,709	55,632	114,799	143,464	148,142	95,886	93,633	81,190	82,525	73,233	91,198	107,742	101,100	115,185	152,689
- Cash & Cash Equivalents	9,884	1,804	2,113	10,027	12,851	8,229	7,588	17,940	11,631	5,997	5,338	5,412	6,085	9,991	7,564
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	128	241	375	393	579	476	59	147	125	19	-5	-31	-84	-84	-84
+ Total Debt	7,607	8,224	6,636	12,404	22,055	26,346	33,542	27,322	24,593	31,402	26,695	25,230	24,987	26,711	24,936
Enterprise Value	29,545	62,235	119,678	146,133	156,169	110,813	101,724	78,570	82,891	97,246	111,368	126,556	118,739	130,244	167,928
Total Capital	9,513	12,171	13,119	25,531	40,636	44,977	52,614	46,494	44,107	45,803	43,015	40,887	41,208	38,125	38,583
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt / EV	0.26	0.13	0.06	0.08	0.14	0.24	0.33	0.35	0.3	0.32	0.24	0.2	0.21	0.21	0.15
EV/Sales	3.52	6.41	10.68	5.87	4.78	3.65	3.9	3.55	3.69	3.94	4.08	4.64	4.38	4.53	5.7
EV/EBITDA	7.22	14.51	24.58	8.96	6.71	5.9	6.6	7.32	7.72	8.53	8.63	9.68	10.3	9.75	11.61
EV/EBIT	7.8	15.52	26.45	9.57	7.04	6.28	7.2	8.45	8.88	9.8	10.26	11.53	13.44	12.29	14.35
EV/Cash Flow to Firm	7.78	18.03	35.96	11.11	7.16	6.22	8.28	8.58	8.14	11.83	9.18	12.91	13.53	11.32	15.39
EV/Free Cash Flow to Firm	7.78	18.03	35.96	11.11	7.16	6.22	8.28	8.58	8.14	11.83	9.18	12.91	12.68	10.83	14.64
Diluted Market Cap	32,332	58,127	127,275	155,246	153,910	97,246	94,493	81,815	82,979	73,582	91,634	108,343	101,911	115,924	154,039
Diluted Enterprise Value	30,184	64,789	132,173	158,016	163,693	115,839	120,506	91,344	96,066	99,006	112,986	128,130	120,729	132,560	171,327
EV per Share	19.06	41.09	78.29	96.01	106.67	82.76	77.83	60.53	65.27	77.36	88.67	100.84	95.14	104.45	134.99
TTM Sales	8,385	9,702	11,202	24,890	32,639	30,390	26,107	22,127	22,449	24,689	27,305	27,281	27,116	28,754	29,442
TTM EBITDA	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	11,531	13,363	14,461
TTM Operating Income	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,838	10,596	11,701
TTM Cash Flow to Firm	3,796	3,452	3,328	13,152	21,825	17,808	12,282	9,154	10,178	8,220	12,134	9,806	8,778	11,506	10,909
TTM Free Cash Flow to Firm	3,796	3,452	3,328	13,152	21,825	17,808	12,282	9,154	10,178	8,220	12,134	9,806	9,363	12,029	11,472

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	8.88	18.19	40.99	12.11	7.24	5.7	7.94	9.74	9.07	9.01	8.05	11.94	11.86	10.21	14.56
EV/EBIT	7.8	15.52	26.45	9.57	7.04	6.28	7.2	8.45	8.88	9.8	10.26	11.53	13.44	12.29	14.35
Enterprise Value	29,545	62,235	119,678	146,133	156,169	110,813	101,724	78,570	82,891	97,246	111,368	126,556	118,739	130,244	167,928
Low Price	17.23	20.68	36.94	63.5	86	70.83	63.76	60.32	60.89	56.56	57.93	57.17	72.87	62.07	88.57
EV/Sales	3.52	6.41	10.68	5.87	4.78	3.65	3.9	3.55	3.69	3.94	4.08	4.64	4.38	4.53	5.7
EV/EBITDA	7.22	14.51	24.58	8.96	6.71	5.9	6.6	7.32	7.72	8.53	8.63	9.68	10.3	9.75	11.61
Price/Earnings	11.31	21.46	37.33	11.86	8.18	7.1	20.23	14.88	15.32	595.39	14.65	23.46	17.85	239.97	17.94
Price/Earnings Average	11.04	16.51	27.87	11.27	8.61	8.29	20.43	17.57	15.49	703.34	13.65	18.32	17.47	201.45	16.28
Price/Earnings High	12.02	22.53	37.84	14.69	9.97	10.23	24.36	21.31	16.62	878.57	14.95	24.53	19.45	256.93	18.81
Price/Earnings Low	9.52	12.08	18.36	7.99	6.95	7.02	18.01	14.35	14.36	578.02	11.69	15.62	16.05	161.25	12.95
Price/Book Value	17.84	15.01	18.79	11.27	8.23	5.28	4.92	4.27	4.26	5.09	5.59	6.87	6.2	10.02	11.12
Price/Book Value Average	17.41	11.55	14.03	10.71	8.66	6.16	4.97	5.04	4.3	6.02	5.2	5.36	6.07	8.41	10.09
Price/Book Value High	18.96	15.76	19.05	13.96	10.03	7.6	5.93	6.11	4.62	7.51	5.7	7.18	6.76	10.73	11.66
Price/Book Value Low	15.02	8.45	9.24	7.59	6.99	5.22	4.38	4.12	3.99	4.94	4.46	4.57	5.58	6.73	8.02
Price/Tangible Book Value	6.61	-17.1	-86.71	40.14	19.25	10.4	-123.53	48.36	17.38	-3.18	-4.4	-6.73	-8.41	-12.78	-57.1
Price/Tangible Book Value Average	6.45	-13.16	-64.72	38.15	20.27	12.14	-124.71	57.07	17.57	-3.76	-4.1	-5.26	-8.24	-10.72	-51.81
Price/Tangible Book Value High	7.02	-17.95	-87.87	49.75	23.47	14.97	-148.75	69.22	18.86	-4.7	-4.49	-7.04	-9.17	-13.68	-59.87
Price/Tangible Book Value Low	5.56	-9.63	-42.65	27.04	16.36	10.29	-109.94	46.63	16.29	-3.09	-3.51	-4.48	-7.57	-8.58	-41.2
Price/Sales	3.78	5.73	10.25	5.76	4.54	3.16	3.59	3.67	3.68	2.97	3.34	3.95	3.73	4.01	5.19
Price/Sales Average	3.69	4.41	7.65	5.48	4.78	3.68	3.62	4.33	3.72	3.5	3.11	3.08	3.65	3.36	4.71
Price/Sales High	4.02	6.02	10.39	7.14	5.53	4.54	4.32	5.25	3.99	4.38	3.41	4.13	4.06	4.29	5.44
Price/Sales Low	3.18	3.23	5.04	3.88	3.86	3.12	3.19	3.54	3.44	2.88	2.66	2.63	3.35	2.69	3.74
Price/Cash Flow	8.71	17.41	36.97	11.19	6.97	5.62	7.87	9.67	9.02	8.97	8.01	11.88	12.63	10.64	15.24
Price/Cash Flow Average	8.5	13.4	27.6	10.64	7.34	6.57	7.94	11.41	9.12	10.59	7.46	9.27	12.36	8.93	13.83
Price/Cash Flow High	9.26	18.28	37.47	13.87	8.5	8.1	9.48	13.84	9.79	13.23	8.18	12.41	13.76	11.39	15.98
Price/Cash Flow Low	7.34	9.8	18.19	7.54	5.92	5.56	7	9.32	8.46	8.7	6.39	7.91	11.36	7.15	11
Price/Free Cash Flow Average	8.67	14	30.6	11.51	7.63	6.66	8.02	11.5	9.17	10.64	7.5	9.33	11.61	8.57	13.21
Price/Free Cash Flow High	9.44	19.1	41.54	15.01	8.83	8.21	9.56	13.94	9.85	13.29	8.22	12.48	12.93	10.93	15.26
Price/Free Cash Flow Low	7.48	10.24	20.16	8.16	6.16	5.64	7.07	9.39	8.5	8.75	6.42	7.95	10.67	6.86	10.5
EV/Sales Average	3.43	5.1	8.09	5.59	5.08	4.29	4.62	4.76	4.3	4.53	3.89	3.81	4.34	3.94	5.29
EV/Sales High	3.76	6.71	10.82	7.26	5.83	5.15	5.32	5.68	4.57	5.41	4.19	4.85	4.76	4.87	6.03
EV/Sales Low	2.93	3.92	5.48	3.99	4.16	3.73	4.19	3.97	4.03	3.91	3.45	3.36	4.05	3.27	4.33
EV/EBITDA Average	7.04	11.54	18.61	8.53	7.12	6.95	7.82	9.82	8.98	9.81	8.24	7.95	10.22	8.48	10.78
EV/EBITDA High	7.71	15.17	24.9	11.07	8.17	8.34	9.01	11.72	9.55	11.7	8.87	10.13	11.19	10.47	12.27
EV/EBITDA Low	6	8.86	12.6	6.09	5.83	6.04	7.1	8.19	8.42	8.46	7.29	7	9.52	7.04	8.81
EV/EBIT Average	7.6	12.34	20.03	9.11	7.47	7.4	8.53	11.33	10.33	11.28	9.79	9.47	13.33	10.7	13.32
EV/EBIT High	8.33	16.23	26.8	11.83	8.58	8.88	9.82	13.52	10.99	13.45	10.54	12.07	14.6	13.21	15.16
EV/EBIT Low	6.48	9.47	13.56	6.51	6.11	6.43	7.74	9.45	9.68	9.72	8.67	8.34	12.42	8.87	10.89
Last Price	20.46	36.73	75.1	94.26	101.19	71.61	71.64	62.55	64.98	58.26	72.61	85.85	81.01	92.37	122.74
High Price	21.75	38.56	76.11	116.83	123.37	103.1	86.27	89.54	70.5	85.97	74.12	89.74	88.29	98.9	128.7
Enterprise Value Average	28,793	49,468	90,593	139,109	165,743	130,508	120,542	105,353	96,495	111,934	106,303	103,920	117,800	113,332	155,828
Enterprise Value High	31,560	65,065	121,241	180,585	190,397	156,644	138,768	125,752	102,622	133,488	114,447	132,411	129,004	139,964	177,391
Enterprise Value Low	24,555	37,984	61,365	99,417	135,687	113,434	109,347	87,824	90,417	96,520	94,112	91,535	109,760	94,037	127,469

Shares Outstanding	1,506	1,519	1,534	1,499	1,422	1,310	1,308	1,282	1,266	1,254	1,254	1,247	1,246	1,246	1,241
Diluted Weighted Avg Shares	1,580	1,583	1,695	1,647	1,521	1,358	1,319	1,308	1,277	1,263	1,262	1,262	1,258	1,255	1,255
Basic Weighted Avg Shares	1,550	1,515	1,529	1,522	1,464	1,339	1,307	1,298	1,270	1,257	1,256	1,255	1,248	1,247	1,244
Revenue per Share	5.41	6.41	7.33	16.35	22.29	22.7	19.97	17.05	17.68	19.64	21.74	21.74	21.73	23.06	23.67
EBITDA per Share	2.64	2.83	3.19	10.72	15.91	14.03	11.79	8.26	8.46	9.07	10.28	10.42	9.24	10.72	11.62
Operating Income per Share	2.45	2.65	2.96	10.03	15.16	13.17	10.81	7.16	7.35	7.9	8.64	8.74	7.08	8.5	9.41
Basic EPS, GAAP	1.81	1.71	2.01	7.95	12.37	10.08	3.54	4.2	4.24	0.1	4.96	3.66	4.54	0.38	6.84
Basic EPS from Cont Ops	1.8	1.7	2	7.92	12.37	10.07	3.55	4.21	4.22	0.07	4.94	3.64	4.5	0.38	6.84
Diluted EPS, GAAP	1.77	1.64	1.81	7.35	11.91	9.94	3.51	4.17	4.22	0.1	4.93	3.64	4.5	0.38	6.78
Diluted EPS from Cont Ops	1.76	1.63	1.8	7.32	11.9	9.93	3.52	4.17	4.2	0.07	4.91	3.62	4.46	0.38	6.78
Dividend per Share	- -	- -	- -	- -	1.28	1.83	2.09	2.29	2.54	2.74	2.87	2.96	3.05	3.14	3.22
Cash Flow per Share	2.35	2.11	2.03	8.42	14.52	12.73	9.1	6.47	7.2	6.5	9.06	7.23	6.42	8.68	8.05
Free Cash Flow per Basic Share	2.35	2.11	2.03	8.42	14.52	12.73	9.1	6.47	7.2	6.5	9.06	7.23	5.95	8.26	7.6
Cash & Equivalents per Share	6.39	1.23	1.39	6.65	9.98	8.88	19.52	23.18	19.17	5.89	5.19	5.09	5.82	9.28	7.73
Book Value per Share	1.15	2.45	4	8.37	12.3	13.56	14.55	14.66	15.27	11.44	13	12.5	13.06	9.22	11.04
Tangible Book Value per Share	3.1	-2.15	-0.87	2.35	5.26	6.89	-0.58	1.29	3.74	-18.31	-16.5	-12.75	-9.63	-7.23	-2.15

Gilead Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)